Evidence map›Paper›PMID 22586033›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

15 kDa granulysin causes differentiation of monocytes to dendritic cells but lacks cytotoxic activity.

Carol Clayberger, Michael W Finn, Tianhong Wang, Reena Saini, Christine Wilson, Valarie A Barr, Marianna Sabatino, Luciano Castiello, David Stroncek, Alan M Krensky

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Carol ClaybergerLaboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Michael W Finn
Tianhong Wang
Reena Saini
Christine Wilson
Valarie A Barr
Marianna Sabatino
Luciano Castiello
David Stroncek
Alan M Krensky
Center for Cancer Research · USNational Cancer Institute · USNational Institutes of Health · USNational Institutes of Health Clinical Center · US

Funding

Confocal Core for the Laboratory of Cellular and Molecular BiologyZICBC010978 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PALLIKKUTH, SANDEEP · 2009 to 2025
$7.6M
Function of granulysinZIABC011026 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KRENSKY, ALAN · 2009 to 2012
$3.5M
Develop novel assays for assessing cellular and gene therapiesZIACL002119 · CLC · CLINICAL CENTER · PI STRONCEK, DAVID · 2010 to 2025
$0k
Development of novel cell and gene therapiesZIACL002120 · CLC · CLINICAL CENTER · PI STRONCEK, DAVID · 2009 to 2025
$0k
Intramural NIH HHS ZIA BC011026
6 · The paper itself

Abstract

Granulysin is expressed as two isoforms by human cytotoxic cells: a single mRNA gives rise to 15 kDa granulysin, a portion of which is cleaved to a 9 kDa protein. Studies with recombinant 9 kDa granulysin have demonstrated its cytolytic and proinflammatory properties, but much less is known about the biologic function of the 15 kDa isoform. In this study, we show that the subcellular localization and functions of 9 and 15 kDa granulysin are largely distinct. Nine kilodalton granulysin is confined to cytolytic granules that are directionally released following target cell recognition. In contrast, 15 kDa granulysin is located in distinct granules that lack perforin and granzyme B and that are released by activated cytolytic cells. Although recombinant 9 kDa granulysin is cytolytic against a variety of tumors and microbes, recombinant 15 kDa granulysin is not. The 15 kDa isoform is a potent inducer of monocytic differentiation to dendritic cells, but the 9 kDa isoform is not. In vivo, mice expressing granulysin show markedly improved antitumor responses, with increased numbers of activated dendritic cells and cytokine-producing T cells. Thus, the distinct functions of granulysin isoforms have major implications for diagnosis and potential new therapies for human disease.

Indexed as

Cytotoxicity, ImmunologicAnimalsAntigens, Differentiation, T-LymphocyteCell DifferentiationDendritic CellsFlow CytometryHumansLymphocytes, Tumor-InfiltratingMiceMice, Inbred BALB CMice, Inbred C57BLMice, TransgenicMicroscopy, ConfocalMonocytesNeoplasms, ExperimentalProtein IsoformsAntigens, Differentiation, T-LymphocyteGNLY protein, humanProtein Isoforms

Identifiers

PMID22586033
PMCPMC3370151
OpenAlexW2170454176

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.